Hlavin, Callie https://orcid.org/0000-0002-0825-1782
Donohue, Jack K.
Mayer, Natasha
Lu, Liling
Bernardi, Karla
Brown, Joshua
Neal, Matthew D.
Courcoulas, Anita
Funding for this research was provided by:
Foundation for the National Institutes of Health (T32GM075770)
Article History
Received: 2 December 2025
Accepted: 3 April 2026
First Online: 28 April 2026
Declarations
:
: The senior author (AC) has a research grant from Allurion Technologies and Eli Lilly. MDN is the Chief Medical Officer of Haima Therapeutics. He reports honoraria from Haemonetics, Octapharma, Takeda, and Janssen. He reports research funding from Haemonetics, Alexion, DARPA, DoD, and the NIH. The remaining authors have no conflicts of interest. The remaining authors have no financial conflicts of interest to disclose.